Skip to main content
. 2018 Mar 26;7:e32208. doi: 10.7554/eLife.32208

Table 1. Associations with death in 817 subjects with admission retinal exam and retinopathy-positive paediatric cerebral malaria, 137 of whom died and 680 survived.

Retinal features are presented for the worse eye. Estimates are from unadjusted logistic regression. p≤0.01 is bold.


Variable name
Units Died Survived Association with death
Numerical characteristics Numerical characteristics OR 95% CI p
Demographics
Age
(median, IQR)
months 35 23–59 136 39 27–58.75 680 0.99 0.00–1.00 0.43
Weight
(median, IQR)
kg 11 9–15 137 12 10–15 680 0.97 0.93–1.02 0.22
Height
(median, IQR)
cm 89 79–103 135 92 83–103 671 0.99 0.98–1.00 0.15
Sex
(%)
boy 48.9 66 50.29 680 1.06 0.73–1.53 0.77
girl 51.1 69 49.71
Clinical
Coma score
(%)
0 23.3 32 9.85 67 3.57 2.13–5.88 <0.001
1 41.6 57 37.7 256 2.13 1.28–3.57 0.003
2 35.0 48 52.5 357 reference
Respiratory distress
(%)
Present 48.9 67 39.0 265 1.5 1.04–2.17 0.03
Absent 51.1 70 61.0 415
Convulsions at admission (%) Present 12.4 17 14.9 98 0.83 0.45–1.44 0.51
Absent 87.6 120 85.4 574
Temperature
(median, IQR)
degrees C 38.7 37.8–39.5 137 38.9 38–39.7 680 0.89 0.77–1.03 0.12
Systolic BP
(median, IQR)
mmHg 100 90–110 127 100 90–110 652 0.99 0.99–1.01 0.63
Pulse
(median, IQR)
beats/min 156 136.5–170.5 137 152 136.75–169 678 1.0 0.99–1.01 0.98
Duration of coma
(median, IQR)
Hours 7 4–18 110 7 4–17 558 0.99 0.98–1.01 0.29
Duration of fever
(median, IQR)
Hours 48 33.25–72 130 60 43.25–72 652 0.99 0.99–1.00 0.09
Hypoglycaemia on ward (%) Present 14.6 20 7.81 53 2.02 1.16–3.5 0.012
Absent 85.4 117 92.1 626
Laboratory
Parasitaemia
(median, IQR)
#cells 79052 16695–357000 134 68076 11700–298000 649 1.0 0.99–1.00 0.27
White cell count
(median, IQR)
#cells 11300 6925–18225 120 9200 6600–13725 630 1.0 1.00–1.00 0.004
Haematocrit
(median, IQR)
% 19.5 15–24.75 136 20 15.8–25 673 0.99 0.97–1.02 0.69
Lactate
(median, IQR)
mmol/L 8.75 5.38–12.78 92 5.3 3.2–9.9 519 1.11 1.06–1.16 <0.001
HRP2
(median, IQR)
ng/ml 8838.5 4435.5–15102.3 120 5765 2471.5–10031 609 1.0 1.00–1.00 0.004
HIV
(%)
Positive 22.5 29 14.9 88 1.66 1.03–2.66 0.036
Negative 77.5 100 85.1 503
Ophthalmoscopy
Retinal haemorrhage
(%)
>50 16.0 22 4.7 32 3.4 1.78–6.5 <0.001
21 to 50 11.0 15 6.50 44 1.69 0.85–3.34 0.14
6 to 20 13.1 18 19.0 129 0.69 0.38–1.27 0.23
1 to 5 32.9 45 42.9 291 0.76 0.48–1.23 0.27
None 27.0 37 27.0 183 reference
Macular whitening
(%)
>1 23.9 32 14.8 100 2.31 1.16–4.59 0.017
1/3 to 1 28.4 38 25.1 170 1.61 0.83–3.12 0.16
<1/3 37.3 50 45.2 306 1.18 0.63–2.22 0.61
None 10.5 14 14.9 101 reference
Foveal whitening
(% of foveal zone)
>2/3 23.3 31 11.5 78 3.39 1.83–6.26 <0.001
1/3 to 2/3 18.1 24 15.2 103 1.99 1.05–3.74 0.03
<1/3 42.8 57 46.8 316 1.54 0.90–2.62 0.11
none 15.8 21 26.5 179 reference
Temporal whitening
(%)
3 10.0 13 12.9 87 0.83 0.41–1.66 0.60
2 24.6 32 18.4 124 1.43 0.83–2.47 0.20
1 41.5 54 43.1 290 1.03 0.64–1.67 0.89
none 23.9 31 25.6 172 reference
Orange vessels, temporal quadrant (%) present 44.6 58 21.7 145 2.9 1.96–4.3 <0.001
absent 55.4 72 78.3 523
White vessels, temporal quadrant (%) present 25.4 33 24.3 162 1.06 0.69–1.64 0.78
absent 74.6 97 75.8 506
White capillaries
(%)
present 26.9 35 33.1 221 0.75 0.49–1.13 0.17
absent 73.1 95 66.9 447
Papilloedema
(%)
present 39.0 53 21.8 148 2.29 1.55–3.38 <0.001
absent 61.0 83 78.2 530
Disc hyperaemia
(%)
present 48.7 54 35.3 212 1.73 1.15–2.61 0.008
absent 51.4 57 64.7 388